Korify Capital
Venture capitalSeries A–Late Stage · 6 people tracked
Find your way into Korify Capital
533 people in our graph share verified history with the Korify Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Korify Capital invests in companies advancing longevity and mental health, aiming to help people live long, healthy, and fulfilled lives. The firm backs unique, pioneering approaches led by strong teams that are redefining their sectors. Its investment focus is on Series A through Series C rounds in companies that have demonstrated strong traction, achieved proof of concept, and are positioned to become future leaders in their fields.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website & curated & public directories
What they invest in
from 14 of 16 portfolio companiesBiotech ×11Longevity ×7Healthtech ×6Deep Tech ×5Consumer ×2Digital Health ×2Medical Devices ×2AI & Machine Learning ×1
HQs:United States×6Switzerland×1Netherlands×1
Investments · 16 tracked
founders shown can be your intro pathBy year:2026 · 12021 · 12 dated
Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.
BiotechDigital HealthMental HealthMountain View, US
Amit Etkin(Founder)inAdam Savitz(Executive Officer)inNicholas C. Smith(Executive Officer)inMichael Hanley(Executive Officer)Aaron Weaver(Director)Po Yu (Jeff) Chen(Director)
Co-investorsAble PartnersAlpha Wave GlobalInVivium CapitalK2 HealthVenturesVivo CapitalWhat If Ventures+2 more
Aera Health develops a platform built on P4 medicine principles to enable personalized and proactive healthcare engagement for doctors and patients.
AI & Machine LearningDigital HealthHealthtechBasel, CH
Biotech company developing small molecule therapeutics to activate cellular quality control machinery for treating neurodegenerative diseases.
Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools.
BiotechDeep TechLongevity
Diogo R. Feleciano(Co-Founder & CSO)inDarci J. Trader(Scientific Co-Founder / Advisor)João Ribas(Interim-CBO)in
Co-investorsApollo Health VenturesNovo Holdings
Distributed development company building a pipeline of therapies to prevent age-related illness and extend healthspan.
Cambrian Bio is a clinical-stage drug development company creating precision therapeutics that target metabolic pathways which decline with age, such as AMPK and mTOR.
BiotechHealthtechLongevityNew York, US
James G. Peyer(Executive Officer, Director)inJames Peyer(CEO, Founder, Board Director)inJames Peyer, PhD(Founder)inMark Nuttall(Chief Business Officer)inRuth Thieroff-Ekerdt(Chief Medical Officer)inWilliam DeVaul(Executive Officer)in
Co-investorsCatalio Capital Management, LPFuture VenturesKhosla VenturesSprint VcStrawberry Creek VenturesTA Ventures+1 more
Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan.
BiotechHealthtechLongevity
Christian Angermayer(Founder)in
Co-investorsCatalio Capital Management, LPP53 Invest
Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases.
BiotechDeep TechHealthtechLongevityMedical DevicesUtrecht, NL
Peter de Keizer(Founder and Managing Director)inTobias Madl(Head of Structural Biology, Scientific Co-founder)
Co-investorsCoastCapCurie Capital
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes.
BiotechFemTechHealthtechMedical DevicesAustin, US
Dina Turner(Co-founder & Chief Executive Officer)inMartin Varsavsky(Co-founder & Chairman)inDina Radenkovic(Executive Officer, Director)in
BoardDusan Perovic(Director)inDylan Morris(Director)Maryanna Saenko(Director)in
Co-investorsBold Capital PartnersFuture VenturesIngeborg InvestmentsJazzya InvestmentsLux CapitalMyelin VC+11 more
BiotechSt. Petersburg, US
Christopher Shepard(Executive Officer, Director)inJarod Rutledge(Director)
BoardNils Regge(Director)
Co-investorsApollo Health Ventures
Nula Therapeutics develops targeted small-molecule medicines that correct how the nuclear envelope regulates gene expression and cellular function.
BiotechDeep TechLongevity
Refoxy is a science-driven company focused on drug discovery, medicinal chemistry, and bioinformatics.
BiotechDeep TechHealthtechLongevity
Victor Bustos(Co-Founder & CEO)inWolfgang Link(Scientific Co-founder & Advisor)inAndrew Pierce(Chief Science Officer)in
Co-investorsApollo Health VenturesBoehringer Ingelheim Venture FundHTGF
Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease.
BiotechDeep TechLongevityBoston, US
Co-investorsApollo Health VenturesCoastCap
Biopharmaceutical company developing first-in-class therapeutics for rare genetic and neurodegenerative diseases with a focus on autophagy enhancement.
BiotechLewes, US
Jens Eckstein(Executive Officer, Director)
Storypod makes audio players and screen-free content for young children, including the Eddi all-in-one sleep, play, and learning system and Craftie/Token audio collections featuring licensed stories such as Eric Carle's "The Very Hungry Caterpillar." Its products combine sound machine and nightlight functions with expert-designed learning content aimed at early childhood development.
ConsumerEdTechHardware
Co-investorsInfinitas CapitalMiami Angels
Wonder Brands develops and sells essential household consumer products across Latin America, using an online-first omnichannel model with in-house design, sourcing, and supply chain control.
ConsumerDirect to ConsumerE-commerce
Matias Casoy(Founder)inFederico Malek(Founder)inNicolás Gonzalez Luna(Founder)in
Co-investorsFlucas VenturesHi VenturesKube VCMarathon VenturesNazcaALLVP+5 more
Exits · 1
IPOs and acquisitions across the tracked portfolioAlto NeuroscienceNYSE: ANRO
Portfolio news
latest coverage across their companies
Alto Neuroscience · finance.yahoo.com · Aug 16, 2026
Gameto · smartcompany.com.au · Jul 17, 2026
Storypod · kidspacestuff.com · Jul 5, 2026
Nula Therapeutics · cen.acs.org · Apr 16, 2026
Frequently asked questions
- How many investments has Korify Capital made?
- Korify Capital has 15 tracked investments, including 1 dated in the last 24 months.
- What stage does Korify Capital invest at?
- Korify Capital invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does Korify Capital focus on?
- Korify Capital focuses on AI & Machine Learning, Biotech, Healthtech, Longevity, Mental Health.
- Who does Korify Capital co-invest with?
- Korify Capital most often shares deals with Catalio Capital Management, LP, CoastCap, Future Ventures, among 27 tracked co-investors.
Images
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Equitage Ventures is an early-stage investor providing capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.
Kinnevik is a leading growth investor, active owner, and operational partner providing patient capital to technology-enabled challenger businesses in Europe and the US.